Table 2.
Medical eligibility criteria for hormonal contraceptive use in women with SAH
| COC/RING/PATCH | CIC | POP | DMPA | ENG/LNG IMPLANTS | LNG-IUS | |
|---|---|---|---|---|---|---|
| Controlled SAH | 3 | 3 | 1 | 2 | 1 | 1 |
| Uncontrolled SAH (mmHg) | ||||||
| 140–159×90–99 | 3 | 3 | 1 | 2 | 1 | 1 |
| ≥160×≥100 | 4 | 4 | 2 | 3 | 2 | 2 |
| Vascular disease | 4 | 4 | 2 | 3 | 2 | 2 |
Note: Reprinted from Medical eligibility criteria for contraceptive use, Fifth edition, World Health Organization, 1–267, Copyright 2015. Available from: http://www.who.int/reproductivehealth/publications/family_planning/MEC-5/en/.13
Abbreviations: CIC, combined injectable contraceptive; COC, combined oral contraceptive; DMPA, depot medroxyprogesterone acetate; ENG, etonogestrel; LNG, levonorgestrel; LNG-IUS, levonorgestrel-releasing intrauterine system; POP, progestogen-only pill; SAH, systemic arterial hypertension.